Dr Teresa Leung
MBBS FRACP FRCPA
Dr Teresa Leung is a general haematologist with a broad range of clinical Haematology experiences. She obtained her Bachelor of Medicine from the University of Melbourne, and undertook her haematology training at institutions including Austin Hospital, (clinical and diagnostic laboratory haematology), as well as the Royal Melbourne Hospital (clinical haematology and bone marrow transplant service).
Dr Leung works both as a Clinical and Laboratory Haematologist at Northern Health, Epping. She has an special interest in multiple myeloma and low grade lymphomas, and is a visiting haematologist to Alfred Health’s Myeloma clinic.
Dr Leung has a passion for teaching and clinical research, and has produced several publications together with her trainees, as well as serving as a mentor for junior medical staff and medical students from University of Melbourne.
Dr Leung is pleased to see referrals on both malignant and non-malignant blood disorders, as well as provide advice on abnormal haematological investigations.
Apart from English, Dr Leung also speaks fluent Cantonese, Mandarin and Japanese.
Dr Leung is a general haematologist with a broad range of clinical experience, with a special interest in myeloma and low grade lymphoma. She is pleased to see referrals on both malignant and non-malignant blood disorders, as well as providing advice on abnormal haematological investigations. She speaks fluent Cantonese, Mandarin and Japanese.
- Lukito, Leung et al; Active Treatment of Selected Elderly Patients with Acute Myeloid Leukaemia Improves Survival: Results from the establishment of acute leukaemia service at the Northern Hospital; Poster Publication at Haematology Australia Association Symposium; 2016
- Lim, Leunget al; Venous Thromboembolism in North East Melbourne; Poster publication at Royal Australasian College of Physicians Congress; 2014
- Gregory, Leunget al; Rituximab is associated with improved survival for aggressive B cell CNS Lymphoma; Neuro-Oncology; 2013
- Leungand Turner et al; Reversible bone marrow reticulin fibrosis as a side effect of Romiplostim therapy for the treatment of chronic refractory immune thrombocytopenia. Pathology Aug 2011; 43:520-22.